372 related articles for article (PubMed ID: 9629877)
1. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics.
Morrow GR; Roscoe JA; Kirshner JJ; Hynes HE; Rosenbluth RJ
Support Care Cancer; 1998 May; 6(3):244-7. PubMed ID: 9629877
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting.
Spitzer TR; Grunberg SM; Dicato MA
Support Care Cancer; 1998 May; 6(3):233-6. PubMed ID: 9629875
[TBL] [Abstract][Full Text] [Related]
3. Optimal selection of antiemetics in children receiving cancer chemotherapy.
Roila F; Aapro M; Stewart A
Support Care Cancer; 1998 May; 6(3):215-20. PubMed ID: 9629872
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic drugs.
Cranwell-Bruce L
Medsurg Nurs; 2009; 18(5):309-13; quiz 314. PubMed ID: 19927970
[No Abstract] [Full Text] [Related]
5. [Management of nausea, vomiting and anorexia due to anticancer agents].
Shimada K; Taguchi S
Gan To Kagaku Ryoho; 2003 Jun; 30(6):760-4. PubMed ID: 12852341
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacology and clinical experiences with serotonin (5-HT3) receptor antagonists].
Scholz J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):626-8. PubMed ID: 9445561
[No Abstract] [Full Text] [Related]
7. Serotonin antagonists: treatment of chemotherapy-induced emesis.
Barisano A; Mehl B; Bradbury K
Mt Sinai J Med; 1992 Oct; 59(5):433-7. PubMed ID: 1435844
[No Abstract] [Full Text] [Related]
8. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
Gridelli C
Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
[TBL] [Abstract][Full Text] [Related]
9. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
de Wit R; Aapro M; Blower PR
Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
[TBL] [Abstract][Full Text] [Related]
11. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
Natale JJ
Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
[TBL] [Abstract][Full Text] [Related]
12. Re: 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy.
Hartvig P
J Oncol Pharm Pract; 2007 Mar; 13(1):57-8. PubMed ID: 17621570
[No Abstract] [Full Text] [Related]
13. [Medical treatment of chemotherapy-induced nausea and vomiting].
Herrstedt J
Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
Trigg ME; Higa GM
J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
[TBL] [Abstract][Full Text] [Related]
15. Anticipatory nausea and vomiting.
Aapro MS; Molassiotis A; Olver I
Support Care Cancer; 2005 Feb; 13(2):117-21. PubMed ID: 15599779
[TBL] [Abstract][Full Text] [Related]
16. Advances in use of the 5-HT3 receptor antagonists.
Walton SM
Expert Opin Pharmacother; 2000 Jan; 1(2):207-23. PubMed ID: 11249543
[TBL] [Abstract][Full Text] [Related]
17. Consensus regarding multiple day and rescue antiemetic therapy.
De Mulder PH; Roila F; Kris MG; Marty MM
Support Care Cancer; 1998 May; 6(3):248-52. PubMed ID: 9629878
[TBL] [Abstract][Full Text] [Related]
18. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
Antonarakis ES; Hain RD
Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
[TBL] [Abstract][Full Text] [Related]
19. Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings.
Hickok JT; Roscoe JA; Morrow GR; Stern RM; Yang B; Flynn PJ; Hynes HE; Kirshner JJ; Rosenbluth RJ
Cancer; 1999 Jul; 86(1):64-71. PubMed ID: 10391565
[TBL] [Abstract][Full Text] [Related]
20. Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development.
Rizk AN; Hesketh PJ
Drugs R D; 1999 Oct; 2(4):229-35. PubMed ID: 10659396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]